Literature DB >> 32023208

Cullin 3 targets the tumor suppressor gene ARMC5 for ubiquitination and degradation.

Isadora Pontes Cavalcante1, Anna Vaczlavik1, Ludivine Drougat1, Claudimara Ferini Pacicco Lotfi2, Karine Perlemoine1, Christopher Ribes1, Marthe Rizk-Rabin1, Eric Clauser3, Maria Candida Barisson Villares Fragoso4, Jérôme Bertherat1,5, Bruno Ragazzon1.   

Abstract

ARMC5 (Armadillo repeat containing 5 gene) was identified as a new tumor suppressor gene responsible for hereditary adrenocortical tumors and meningiomas. ARMC5 is ubiquitously expressed and encodes a protein which contains a N-terminal Armadillo repeat domain and a C-terminal BTB (Bric-a-Brac, Tramtrack and Broad-complex) domain, both docking platforms for numerous proteins. At present, expression regulation and mechanisms of action of ARMC5 are almost unknown. In this study, we showed that ARMC5 interacts with CUL3 requiring its BTB domain. This interaction leads to ARMC5 ubiquitination and further degradation by the proteasome. ARMC5 alters cell cycle (G1/S phases and cyclin E accumulation) and this effect is blocked by CUL3. Moreover, missense mutants in the BTB domain of ARMC5, identified in patients with multiple adrenocortical tumors, are neither able to interact and be degraded by CUL3/proteasome nor alter cell cycle. These data show a new mechanism of regulation of the ARMC5 protein and open new perspectives in the understanding of its tumor suppressor activity.

Entities:  

Keywords:  ARMC5; CUL3; adrenocortical tumors; ubiquitination

Mesh:

Substances:

Year:  2020        PMID: 32023208     DOI: 10.1530/ERC-19-0502

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  6 in total

Review 1.  Update on primary bilateral macronodular adrenal hyperplasia (PBMAH).

Authors:  Lucas Bouys; Iacopo Chiodini; Wiebke Arlt; Martin Reincke; Jérôme Bertherat
Journal:  Endocrine       Date:  2021-02-15       Impact factor: 3.633

Review 2.  Primary bilateral macronodular adrenal hyperplasia: definitely a genetic disease.

Authors:  Isadora P Cavalcante; Annabel Berthon; Maria C Fragoso; Martin Reincke; Constantine A Stratakis; Bruno Ragazzon; Jérôme Bertherat
Journal:  Nat Rev Endocrinol       Date:  2022-08-03       Impact factor: 47.564

3.  ARMC5 variants in PRKAR1A-mutated patients modify cortisol levels and Cushing's syndrome.

Authors:  Andrea Gutierrez Maria; Christina Tatsi; Annabel Berthon; Ludivine Drougat; Nikolaos Settas; Fady Hannah-Shmouni; Jerome Bertherat; Fabio R Faucz; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2020-09       Impact factor: 5.900

4.  A novel nonsense mutation in ARMC5 causes primary bilateral macronodular adrenocortical hyperplasia.

Authors:  Wen-Tao He; Xiong Wang; Wen Song; Xiao-Dong Song; Yan-Jun Lu; Yan-Kai Lv; Ting He; Xue-Feng Yu; Shu-Hong Hu
Journal:  BMC Med Genomics       Date:  2021-05-10       Impact factor: 3.063

Review 5.  ARMC Subfamily: Structures, Functions, Evolutions, Interactions, and Diseases.

Authors:  Yutao Huang; Zijian Jiang; Xiangyu Gao; Peng Luo; Xiaofan Jiang
Journal:  Front Mol Biosci       Date:  2021-11-29

6.  ARMC5-CUL3 E3 ligase targets full-length SREBF in adrenocortical tumors.

Authors:  Yosuke Okuno; Atsunori Fukuhara; Michio Otsuki; Iichiro Shimomura
Journal:  JCI Insight       Date:  2022-08-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.